CRME Stock Analysis
CRME - CARDIOME PHARMA CORP listed on NASDAQ.
CRME - Sector: Healthcare, Industry: Biotechnology and Drugs.
CRME gained 0.25% on 11/20/14.
CRME is trading in the range of $7.12 - $9.00 in the past 30 days.
Commodity Channel Index (CCI) is bullish for CRME.
Stock performance base on day of week in the past 90 days.
Our rating on the stock: NEUTRAL with a score of 3/5.
CRME Earnings Date